Please note:

Access to some of the content below is restricted and users need to be registered, and logged in to the SPS site with an NHS access level.

A Guide to Quality Control Chemical Testing of Aseptically Prepared Products

(ATMPs)- The Role of Pharmacy in the Successful Delivery of Advanced Therapy Medicinal Products Information for Chief Pharmacists

Computer Systems Validation

Design, Build and Maintenance of Pharmacy Aseptic Units

Guidance on the Pharmaceutical Issues Concerning Outpatient Parenteral Antibiotic Therapy (OPAT) and Other Outpatient IV Therapy Services

Guidance on Repackaging and Overlabelling Small Batches of Medicines in Pharmacy Departments

Measurement of HEPA filter performance using the dispersed oil particle aerosol test for leak detection in filter installations ed 3

MHRA website link

Microbiological Protocol for the Integrity Testing of Syringes, 2nd Edition April 2013

Monoclonal Antibody (mAb) Products: Guidance on Handling

Multiple Use of Injectable Medicines in Clinical Areas V02 February 2020

Pharmacy Intrathecal Chemotherapy Audit Aide Memoire 4th Edition

The Responsibilities of Chief Pharmacists for Radiopharmaceuticals

Quality Assurance of Aseptic Preparation Services: Standards Handbook 5th Edition 2016

Quality Assurance of Radiopharmaceuticals

Registration of Quality Controllers (MGPS)

Risk Associated with the Outsourcing of the Aseptic Compounding of Parenteral Nutrition
Risk Management of Medicines Stored in Clinical Areas: Temperature Control

Sourcing and Supply of Ready-to-Administer Chemotherapy Doses for the NHS

Sporicidal Issues – Guidance for Aseptic Transfer Processes in the NHS: Addressing Sporicidal Issues

Standard Protocol for deriving and Assessment of Stability – Part 1 Aseptic Preparation (Small Molecules)

Standard Protocol for Deriving and Assessment of Stability -Part 2 Biopharmaceuticals

Standard Protocol for Deriving and Assessment of Stability – Part 3 Oral Liquid Medicines

Standard Protocol for Deriving and Assessment of Stability – Part 4 Parenteral Nutrition

Standard Protocol for Deriving and Assessment of Stability – Part 5 Sterile Products (End Sterilised Products)

Supervision as Applied to Section 10 Aseptic Preparation Activities

Supply of Aseptically Prepared Doses of IMPs Across Legal Boundaries, Version 2, October 2019

Validation Master Plan 1st Edition

Validation of Pharmaceutical Quality Control Analytical Methods 1st Edition

Vial Sharing in Aseptic Services 1st Edition August 2014

Wholesale Distribution Authorisation Audit Edition 1 August 2014

Attachments

Performing a Process Risk Assessment (PRA) to inform contamination control strategy for manufacturing processes within NHS units.
A co-ordinated approach to preventing microbial contamination ensures that aseptically prepared medicines are safe for patients.
Circumstances and potential risks should be considered before preparing eye drops in NHS aseptic units working under Section 10 exemption.
An overview of what defective medicines are and how they should be reported by NHS personnel.
Latest information on supply issues, actions to take, alternatives to use, and expected resolution dates. Content provided by DHSC and MVA team, NHS England.
Summarised recommendations and guidance for medicines requiring monitoring to save you time when you're making monitoring decisions with patients
Information on stability for tablets and capsules to help create MCAs for patients. Find entries and then build and print lists specific to your MCA.
Advice on whether refrigerated medicines can or can’t be used after exposure to out-of-range temperatures. Find entries and build and print lists.